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The purpose of this study was to define the effects of
nitroglycerin on venous tone and to investigate the time
course of nitroglycerin tolerance in the peripheral cir-
culation. The changes in the arterial and venous circu-
lation resulting from an intravenous infusion of nitro-
glycerin(5 J.lg/kg per min) after 5 minutes (acute infusion)
were compared with those changes that occurred after
2 hours (chronic infusion) of the same infusion in six
splenectomized, ganglion-blocked dogs. Hemodynamics,
blood volume and venous and arterial compliance were
measured during each infusion.
Nitroglycerin initially decreased mean arterial pres-
sure from 81.5 ± 2.0 to 57.6 ± 2.7 mm Hg (p < 0.01).
Central blood volume decreased from 21.1 ± 1.4 to 15.9
± 1.1 ml/kg (p < 0.01), while total blood volume and
unstressed vascular volume did not change. In the acute
study, nitroglycerin increased venous compliance 33%
from 1.75 ± 0.14 to 2.32 ± 0.16 ml/mm Hg per kg
Nitroglycerin has been used for almost 100 years for the
treatment of angina pectoris. More recently, there has been
interest in using nitroglycerin and other nitrate preparations
to treat congestive heart failure. Although the therapeutic
benefits of nitrates are apparent, there is evidence that long-
term administration of these agents leads to tolerance (1-3).
In clinical studies, tolerance to nitrates has been demon-
strated by showing no difference in the anti-ischemic effects
compared to placebo at specific time intervals with serial
exercise testing or by showing no change in symptoms in
patients with heart failure (2). Because the major effect of
nitroglycerin is on preload, most investigators believe that
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(p < 0.01) and arterial compliance 33% from 0.049 ±
0.007 to 0.065 ± 0.007 ml/mm Hg per kg (p < 0.01).
At the end of the 2 hour infusion, arterial pressure in-
creased and was now unchanged from control. Central
blood volumehad returned to baseline, 17.8 ± 0.9 m1/kg.
Total blood volume and unstressed vascular volume re-
mained unchanged. With the long-term infusion, both
arterial and venous compliance decreased(p < 0.02) to
0.050 ± 0.006 and 1.50 ± 0.06 ml/mm Hg per kg,
respectively, such that neither value was different from
control. Nitroglycerin levelsremained constant through-
out.
Thus, acute administration of nitroglycerin causes
arterial and venous dilation by increasing compliance in
each vascular bed. The duration of this response is short-
lived with the development of tolerance within 2 hours.
(J Am Coil Cardiol 1987;10:1335-41)
tolerance to nitroglycerin occurs in the venous system. What
specifically happens in the venous system is not known, in
part because in clinical studies it is not possible to measure
the true determinants of venous capacitance-mean circu-
latory filling pressure, venous compliance and unstressed
vascular volume.
Changes in systemic venous tone can be measured in
intact animals by measuring mean circulatory filling pres-
sure. venous compliance and unstressed vascular volume
(4-6). The use of an intact animal model has allowed us to
simultaneously study the heart and the peripheral circula-
tion. This is important because changes in one compartment
of the cardiovascular system can affect changes elsewhere.
For example. a change in volume in the venous system will
affect the heart. In addition, the measurement of systemic
venous tone eliminates the need to extrapolate changes ob-
served in one type of vein to the entire venous system (7).
The purpose of this study, therefore, was to use an intact
dog model to establish the precise changes in the peripheral
circulation and the time course of nitroglycerin-induced
changes in the arterial and venous circulation. Specifically,
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where T = time constant, C = compliance (mllmm Hg)
and R = systemic vascular resistance (mm Hg-min-kg/rnl).
According to equation I, the time constant is inversely
proportional to the slope of a plot of log pressure versus
where k, = arterial pressure plateau (mm Hg), k2 the
arterial driving pressure (mm Hg) and P(t) = instantaneous
pressure (mm Hg).
Arterial compliance was then calculated as:
(3 to 10 mg) into the superior vena cava as previously
described by our laboratory (4-6). This pressure was cal-
culated as: Mean circulatory filling pressure = VPP +
(APP - VPP) x arterial compliance/venous compliance,
where VPP = venous plateau pressure, and APP = arterial
plateau pressure measured at 7 seconds after the start of
asystole. An arterial to venous compliance ratio of 1130 was
assumed (8).
Calculation of venous compliance. Venous compliance
was defined as the change in volume divided by the charge
in pressure of the total systemic venous bed. This compli-
ance measurement was obtained by serial determinations of
mean circulatoryfilling pressure after acute volumechanges
over a range of physiologic venous pressures as previously
described (4,6). Mean circulatory filling pressure was mea-
suredat baselineand then after volumeexpansion of 5 mllkg
with body temperaturedextran and then with a combination
of dextran and blood to increase blood volume 10 mllkg.
After the 5 mllkg volume load with dextran, 5 mllkg of
blood was withdrawn, and this plus another 5 ml/kg of
dextran were used for 10 mllkg volume load. These volume
changes were performed manually by infusions within 30
seconds. This time period was chosen to minimize and re-
verse stress relaxation. There was at least a 10 minute re-
covery period between each measurement of mean circu-
latory filling pressure to allow hemodynamic variables to
return to baseline. Venous compliance was defined as the
reciprocal of the slope of the line obtained by plotting mean
circulatory filling pressure versus blood volume. The un-
stressedvascular volume, or the volume in the blood vessels
at zero transmural pressure, was obtained by extrapolating
this pressure-volume relation to the zero pressure intercept.
Calculation of arterial compliance. The method for
calculatingarterial compliance has been previouslyreported
from our laboratory (4,6). Arterial compliance was mea-
sured based on the simple windkessel model of the circu-
lation (9). The equations used were obtained from an elec-
trical analog of a single capacitor, one resistor circuit. This
model assumes that arterial pressure initially decays mono-
exponentially as a function of time from an initial driving
pressure with a rate constant k-, Instantaneous pressure was
calculated as:
(1)
(2)T = CR,
Methods
we hypothesized that nitroglycerin increased arterial and
venous compliance. These acute effects were altered by the
chronic administration of nitroglycerin that resulted in nor-
malization of compliance and therefore tolerance.
Animal preparation. Six mongrel dogs (18.2 ± 1.4
kg) underwent elective splenectomy through a midline ab-
dominal incision under sterile conditions and general anes-
thesia with halothane and oxygen. The dogs were allowed
to recover for 2 weeks and were then sedated with ace-
promazine (0.02 mg/kg), anesthetized with halothane and
nitrous oxide and intubated. Using sterile technique, a 7F
thermodilution, flow-directed pulmonaryarterycatheter was
inserted percutaneously in the right external jugular vein
and advanced into the pulmonary artery. A 7F angiographic
micromanometer-tipped catheter (Millar Instruments, Inc.)
was inserted percutaneously through the left femoral artery
to measure aortic pressure. A 14 gauge plastic catheter was
then placed in the foreleg for intravenous access. All pres-
sure measurements and experiments were performed with
the animals placed on a warming blanket with their left side
down. The dogs were extubated before the experiments.
Further sedation wasaccomplished withdiazepam (0.5 mglkg)
and hydromorphone (0.3 mg/kg)after recoveryfrom general
anesthesia.
Baseline measurements. After the placementof all cath-
eters, ganglionic blockade was induced with hexamethoni-
um chloride (30 mg/kg). Baseline heart rate and pulmonary
artery, pulmonary artery wedge, right atrial and aortic pres-
sures were then recorded. Cardiac output was measured in
triplicate with the thermodilution technique using a mini-
computer (Edwards, model 951O-A); averaged values were
reported. The thermodilution technique has been verified in
our laboratory using dye-dilution measurements of cardiac
output (4,6). Systemic vascular resistance index was cal-
culated as the difference between aortic and right atrial
pressures divided by the cardiac index.
Central blood volume, defined as the blood volume in
the heart and lungs, was determined by the Stewart-
Hamilton principle using indocyaninegreen dye (4-6). To-
tal blood volume was measured using the Evans Blue tech-
nique. A 0.45% (weight/volume) solution of dye in a total
volume of I ml was injected into the circulation system
through an external jugular vein sheath. Five minutes after
injection, an arterial blood sample of 7 ml was withdrawn.
After centrifugation, the dye concentration was determined
spectrophotometrically. Total blood volume was calculated:
Total blood volume = plasma volume -;- I - hematocrit.
This technique to measure blood volume is comparable to
using radioisotope techniques (5). Mean circulatory filling
pressure was measured after transient asystole (5 to 10 sec-
onds) was produced by a bolus injection of acetylcholine
lACC Vol. 10. No 6
December 1987:1335-41
GOLDBERG ET AL
NITRATE TOLERANCE
1337
Table 1. Effects of Nitroglycerin (5 JLg/kg per min) on Hemodynamics in Six Splenectomized
Dogs After Ganglionic Blockade
Heart rate (beats/min )
Right atr ial pre ssure (rnrn HgJ
Mean aortic pressure (rnrn Hg)
Mean pulm ona ry artery pressure (mm Hg)
Pulmonary artery wedge pressure (mm Hg )
Card iac inde x (ml/min per kg)
Systemi c vascular resistance (mm Hg-min-kg/ml)
Cont rol
109 .7 :!: 3.3
- 1.7 :!: 0 .3
8 1.5 :!: 2.0
10 .8 ± 0 .4
0 .6 :!: 0 .5
126 .1 :!: 6 .5
0 .677 ± 0 .03 1
Nitroglyce rin
(5 min)
114 .2 ± 2.8
- 1.8 :!: 0.6
57 .6 :!: 2.7*
9 .6 :!: 0 .5
1.2 :!: 0 .7
IOR.5 :!: 4 .8
0.567 ± 0 .042
Nitroglyceri n
(2 h)
120 . 1 ± 5 .5
- 1.7 ± 0.4
7U ± 6. 1
10.2 ± 0 .8
2 .0 ± 0 .9
114 .5 ± 11.8
0 .684 :!: 0 .070
Values are mean ± SE after ganglionic blockade with hexameth on ium (30 mg/kg) . *p < 0 .0 1 compared
with control value .
time. Compliance was calculated from equation 2. The vol-
ume of blood shifted into or out of the arterial system is
equal to the product of arterial compliance and the change
in mean aortic pressure.
Experimental protocol. Hemodynamic variables, in-
cluding arterial and venous compliance, were measured un-
der control conditions. On a separate day, control hemo-
dynamic measurements were repeated. and an infusion of
nitroglycerin (5 JLg/kg per min) was begun. Five minutes
after the start of an intravenous infusion, arterial and venous
compliance was measured. On a subsequent day. control
hemodynamic variables were again measured, and nitro-
glycerin (5 JLgtkg per min) was infused for 2 hours, at which
time arterial and venous compliance was measured. The
dose of nitroglycerin had been chosen in pilot studies be-
cause it acutely resulted in a 25% decrease in the mean
aortic pressure. The 2 hour time interval was chosen be-
cause, in pilot studies, the arterial pressure had increased
to ncar control values by this time, despite the continuous
nitroglycerin infusion. Total blood volume and central blood
volume were measured whenever venous compliance was
measured. Nitroglycerin blood levels (National Medical
Services) were measured during the control period and at
5. 15, 30 , 60 and 120 minutes into the study.
This protocol was approved by the animal research com-
mittees of the Tucson Veterans Administration Medical Center
and the Universityof Arizona. Particular attentionwas given
to the welfare of the animals, the adequacy of anesthesia
and the method of instrumentation. During the measurement
of mean circulatory filling pressure. cardiac electrical ac-
tivity resumed spontaneously in all dogs; no seizures oc-
curred. and there was no evidence of pain or suffering as
definedin the FederalAnimal Welfare Act and in accordance
with the NIH Guide for care and use of laboratory animals.
Statistical analysis. Data are expressed as mean ± stan-
dard error of the mean. Statistical analysis was performed
by repeated measures of analysis of variance to compare
serial measurements to control. Venous compliance was
determined by regression analysis using the method of least
squares for each mean circulatory fi lling pressure-blood vol-
ume curve. The volume shifts in the arterial circulation were
compared using a t test for paired values.
Results
Acute hemodynamic and circulatory effects of nitro-
glycerin after 5 minutes (Tables I and 2). At a dose of
5 JLg/kg per min, nitroglycerin initially lowered mean aortic
pressure from 81.5 ± 2.0 to 57.6 :±: 2.7 mm Hg (p <
0.0 1). A representative recording of the rapid fall in arterial
pressure is shown in Figure I. There were no changes in
any other hemodynamic variables, including heart rate. car-
diac output. systemic vascular resistance and right atrial.
Table 2. Effects of Nitroglycerin (5 j.Lg/kg per min) on the Peripheral Circulation and Blood
Volume in Six Splenectomized Dogs After Ganglionic Blockade.
Mean circ ulatory filling pressure (mm Hg)
Venous compl iance (ml/mm Hg per kg)
Unstresse d vasc ular volume (ml/kg)
Arteria l compliance (ml/mm Hg per kg)
Arter ial vo lume shift (ml/kg )
Centra l blood volume (rnl/kg)
Total blood volume (rnl/kg)
Con trol
6 . 1 ± 0 .3
1.75 =0 . 14
- 8.6 :!: 1.0
0 .049 ± 0.00 7
2 1. 1 ± 1.4
74 .7 :!: 2 .3
Nitroglycerin
(5 min )
5 .7 ± 0 .3
2 .32 ± 0 . 16*
- 12. 7 ± 1.1
0 .065 ± 0 .007 *
- 1.9 ± 0.4
15 .9 ± I.l t
69. 2 ± 2 9
Nitroglyceri n
(2 h )
6 .6 :!: 0 .8
1.50 :!: 0 .06 t
- 8 .6 :!: 1.9
0 .050 :!: O.060t
- 1. 1 :!: 0 .2 t
17. 8 ± 0 .9~
73 .8 :!: 3 .5
Valu es are mean ± SE after ganglionic blockade with hexameth onium (30 mg/kg) . *p < 0 .02 : t p < 0 .02;
tp < 0.01. compared with co ntro l value; ~p < 0 .05 . compared with the 5 minute value .
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ECG
pulmonary artery and pulmonary artery wedge pressures.
Central blood volume decreased from 21.1 ± 1.4 to
15.9 ± 1.1 mllkg (p < 0.01). Total blood volume and
central blood volume were unchanged.
The major effects ofnitroglycerin were on the peripheral
circulation (Table 2). Figure 2 shows serial circulatory ar-
rests, from which measurements of mean circulatory filling
pressure and arterial and venous compliance were obtained.
After 5 minutes there was no change in mean circulatory
filling pressure, but venous compliance increased 33%
(p < 0.01) and unstressed vascular volume did not change.
The correlation coefficient for the control compliance curve
was r = 0.998 (p < 0.001), and the correlation coefficient
for the acute nitroglycerin compliance curve was r = 0.987
(p < 0.00 I). Arterial compliance also increased 33% (p <
0.0 I), and the volume of blood transferred out of the arterial
circulation was 1.9 ± 0.4 mllkg. The time constant of decay
in the arterial system did not change (2.2 ± 0.1 versus 2.5
± 0.1 seconds).
Hemodynamic and circulatory effects of nitroglycerin
after 2 hours. (Tables 1and 2). During the 2 hour infusion,
the arterial pressure increased such that it was not different
than control. Similar to the acute responses to nitroglycerin,
there were no changes in any other hemodynamic variables
and total blood volume compared with control. Central blood
volume had returned to baseline. In the peripheral circu-
Figure 1. Recording of aortic andright atrial pres-
sure during the infusion of nitroglycerin (5 I-tg/kg/
min). The black square at the bottom defines the
start of theinfusion. The rapid fall inaortic pressure
is apparent. Time lines at the top are at 1 second
intervals. ECG = electrocardiogram.
Iation, the effects that were seen after the acute infusion
were reversed. Both the venous and arterial compliance
decreased (p < 0.01) compared to their 5 minute values,
and after the 2 hour infusion neither value was different
from control (Table 2). The correlation coefficient for the
chronic venous compliance curve was r = 0.997 (p <
0.00 I). The unstressed vascular volume remained un-
changed. The volume of blood shifted out of the arterial
circulation (1.1 ± 0.2 mllkg) was less (p < 0.05) at 2 hours
than at 5 minutes. The time constant of arterial pressure
decay was unchanged (2.5 ± 0.2 seconds).
There were no differences in baseline hemodynamic val-
ues on the three study days. The nitroglycerin levels were
undetectable during the control period and increased to
15.8 ± 1.5 ng/ml at 5 minutes, 17.0 ± 1.8 ng/ml at 15
minutes, 25.3 ± 7.9 ng/ml at 30 minutes, 28.0 ± 3.6
ng/ml at 60 minutes and 22.0 ± 9.3 ng/ml at 120 minutes.
Discussion
The results of this study show that within 5 minutes of
starting an intravenous infusion of nitroglycerin, there was
arterial and venous dilation. Arterial and venous compliance
increased by 33%. This occurred without changes in total
blood volume or unstressed vascular volume. With contin-
uous infusion, tolerance had developed within 2 hours with
lACC Vo!. 10. No. 6
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a return of arterial and venous compliance to baseline. The
blood pooled in the venous circulation during the acute
infusion was shifted back into the central and aortic com-
partments with chronic administration. These alterations in
vascular tone occurred with no change in the dose and the
serum level of nitroglycerin.
Model to study and measure venous capacitance.
The dog model and experimental techniques used in this
study have been previously described from our laboratory
(4,6) to measure the effects of pharmacologic agents on the
peripheral circulation. This closed chest model has distinct
advantages over previous investigations that used anesthe-
tized, open chest preparations. There is less trauma, the
pericardium is intact and the method evaluates the venous
circulation as a whole. Splenectomy was performed to elim-
inate volume shifts that occur in dogs because the spleen is
a large volume reservoir. Ganglion blockade was used to
evaluate the direct effects of nitroglycerin and minimize
active refl ex compensation in the measurement of venous
compliance.
In clinical studies, changes in central venous or pul-
monary wedge pressure have been equated with changes in
venous tone. These measurements of ventricular preload are
affected by heart rate, chamber stiffness, afterload and con-
tractility (10) . Measurement of right or left atrial pressure,
therefore, cannot be used to reflect the status of the venous
capacitance system. Changes in total vascular capacitance
also cannot be extrapolated from changes in one compart-
ment, for example, in limb vessels (7). Because it is not
possible to study the isolated venous system intact, we stud-
ied venous capacitance in the dog by measuring mean cir-
culatory filling pressure, venous compliance and unstressed
Figure 2. Recordings of aortic and right atrial pressures during
acetylcholine-induced circulatory arrest. Panel A, Control ; Panel
B, After 5 minutes of nitroglycerin; and Panel C, After 2 hours
of infusion. After 5 minutes, the arterial pressure decreases, and
during the chronic infusion the arterial pressure increases . The
arterialpressure plateauand the venous pressureplateau (see Meth-
ods) do not change. The black square at the bottom defines the
start of the infusion. ECG = electrocardiogram.
vascular volume. The mean circulatory filling pressure of a
system was defined by Guyton et al. as " that pressure mea-
sured at all points in the circulatory system if the heart were
stopped suddenly and blood redistributed instantly in such
a manner that all pressures were equal" (11). It is assumed
to be equivalent to the pressure distending the capacitance
vessels.
Mean circulatory fi lling pressure is determined by the
compliance of the system and contained blood volume ( /0) .
The vascular compliance of a system is defined as the change
in vascular volume divided by a concomitant change in
pressure. Because the venous system is 30 times more com-
pliant than the arterial system, changes in whole body com-
pliance are mainly reflected as a change in venous compli-
ance. The compliance of the venous circulation can be obtained
by measuring mean circulatory filling pressure after serial
volume changes and constucting a pressure-volume curve.
Because blood vessels possess nonlinear distensible prop-
erties when measurements are done outside physiologic fill-
ing pressures. it is essential to make these measurements
within a narrow range of pressure and volume changes. A
linear pressure-volume relation has been found to exist be-
tween mean circulatory filling pressures of 5 and 25 mm
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Hg (12). In addition, to minimize reflex changes during
alterations in blood volume, the measurement of compliance
should be performed after ganglion blockade. Finally, the
unstressed vascular volume is defined as that volume of
blood in the vascular system at zero transmural pressure.
This is a virtual volume and can be obtained only by ex-
trapolating a linear portion of the pressure-volume relation
to zero transmural pressure. An increase or decrease in
unstressed vascular volume will represent an increase or
decrease in venous capacitance or may result from changes
in stressed volume in the arterial and pulmonary circuit.
Effect of nitroglycerin. The baseline hemodynamic
changes that occurred after acute nitroglycerin administra-
tion are consistent with earlier reports in dogs (13). Although
nitroglycerin is a known venodilator, the exact mechanism
by which this occurs has not been previously studied. Rothe
(10) and Greenway et al. (14) have previously suggested
that venodilation can occur with a change in venous com-
pliance or unstressed vascular volume, or both. The present
study suggests that the major effect of nitroglycerin is an
increase in venous compliance. After a 5 minute infusion,
mean aortic pressure decreased significantly. Because of the
associated increase in aortic compliance, blood was shifted
out of the large arteries. The increase in venous compliance
with the acute infusion shifted volume from the arterial and
central compartments into the systemic venous system. This
results in a decrease in preload and eventually a decrease
in stroke volume.
Clinical implications and comparison with previous
studies. Tolerance to nitroglycerin, defined as a diminished
response to the same dose, has been documented in various
preparations and clinical studies. In rat aorta and guinea pig
ileum stimulated with norepinephrine, preincubation with
nitroglycerin for 1 hour decreased nitroglycerin's ability to
cause relaxation (15,16). Similar results were seen in strips
of aorta removed from rats that had received a 6 hour in-
fusion of nitroglycerin (17). In patients, nitrate tolerance
has been seen after a 5 day treatment with isosorbide di-
nitrate and a 24 hour treatment with nitroglycerin patches
(1-3,18,19). In these studies, the time course of the de-
velopment of tolerance was not investigated. Because we
examined the specific in vivo effects of nitroglycerin on
venous tone, we were able to document the time course of
these changes. The present study showed that tolerance de-
veloped early. Venous compliance returned to normal within
2 hours in the venous system and, similarly, changes in the
arterial circulation were blunted. Because we were unable
to continually monitor venous compliance, it is possible that
these changes may occur even sooner than we documented.
The mechanisms producing tolerance are not completely
understood but appear to be related to cyclic guanosine
monophosphate (GMP) production. Nitroglycerin has been
shown to increase smooth muscle levels of cyclic GMP
before producing relaxation, and the concentration of cyclic
GMP correlated with the degree of smooth muscle relax-
ation. In tissues showing tolerance, the rise in cyclic GMP
production is blunted (15,16).
Potential limitations of this study. The dose of nitro-
glycerin employed in our study was larger than that most
commonly used in clinical settings. This was done inten-
tionally to maximize changes in vascular tone. To measure
vascular compliance, it is necessary to block reflexes with
hexamethonium. This will decrease baseline vascular tone,
resulting in venodilation. The fact that nitroglycerin still
resulted in venodilation supports our hypothesis. The qual-
itative changes and the time course of tolerance should not
be dose dependent.
Care should be taken in extrapolating these data to pa-
tients with congestive heart failure. Previous work from our
laboratory has shown that there is generalized venoconstric-
tion in an animal model of chronic heart failure (20). Thus,
in heart failure, the venodilatory effects on constricted veins
may be more pronounced than reported in this study. How-
ever, the mechanism of the shift in the vascular volume-
pressure relation should be similar.
We thank Donna Buckley, Chuck Hougland, James Thome and James
Nelson for their technical assistance.
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